首页 > 最新文献

ASIAN CARDIOVASCULAR & THORACIC ANNALS最新文献

英文 中文
Hemoadsorption use in adult cardiac surgery for infective endocarditis: A comprehensive meta-analysis.
IF 0.7 Q3 Medicine Pub Date : 2025-03-28 DOI: 10.1177/02184923251328119
Palak Dutta, Rohit Ganduboina, Cankutay Muderrisoglu, Adithya C Reddy Obulareddy, Keerthi Palagati, Vivekananda Reddy Areddy, Gaddam Ashwith Reddy, Sandeep Sainathan

IntroductionInfective endocarditis (IE) is a severe infection of the endocardium, primarily affecting the heart valves, exhibiting high morbidity and mortality rates. Cardiac surgery for IE with cardiopulmonary bypass (CPB) can further exacerbate the inflammatory response and cytokine production from IE. The current meta-analysis evaluates the use of CytoSorb® hemoadsorption in IE patients undergoing cardiac surgery to determine its efficacy in reducing inflammatory mediators and improving clinical outcomes.MethodsPubMed, Cochrane, Google Scholar, Clinical Trials, and Google Scholar were searched for articles until July 2024. After performing a risk of bias and quality assessment, data on operative times, mortality, and morbidity were extracted for meta-analysis. Statistical Software R (version 4.4.0) was used to calculate odds ratio (OR) and standardized mean differences using a random-effect model with a 95% confidence interval (CI) and p-value less than 0.05.ResultsEight studies, encompassing 1076 patients, were included in the analysis. These comprised three randomized controlled trials and five nonrandomized studies. The majority of these studies exhibited some concerns regarding bias. Hemoadsorption group showed lower discharge mortality (OR: 0.58, 95% CI: 0.33-1.00, p = 0.05) compared to controls, but no significant disparity is observed in other outcomes. In-hospital outcomes also showed higher heterogeneity, with an I² value greater than 50%.ConclusionCytoSorb use in patients undergoing cardiac surgery with CPB used for IE has no impact on operative mortality and morbidity but has a beneficial effect on discharge mortality.

{"title":"Hemoadsorption use in adult cardiac surgery for infective endocarditis: A comprehensive meta-analysis.","authors":"Palak Dutta, Rohit Ganduboina, Cankutay Muderrisoglu, Adithya C Reddy Obulareddy, Keerthi Palagati, Vivekananda Reddy Areddy, Gaddam Ashwith Reddy, Sandeep Sainathan","doi":"10.1177/02184923251328119","DOIUrl":"https://doi.org/10.1177/02184923251328119","url":null,"abstract":"<p><p>IntroductionInfective endocarditis (IE) is a severe infection of the endocardium, primarily affecting the heart valves, exhibiting high morbidity and mortality rates. Cardiac surgery for IE with cardiopulmonary bypass (CPB) can further exacerbate the inflammatory response and cytokine production from IE. The current meta-analysis evaluates the use of CytoSorb<sup>®</sup> hemoadsorption in IE patients undergoing cardiac surgery to determine its efficacy in reducing inflammatory mediators and improving clinical outcomes.MethodsPubMed, Cochrane, Google Scholar, Clinical Trials, and Google Scholar were searched for articles until July 2024. After performing a risk of bias and quality assessment, data on operative times, mortality, and morbidity were extracted for meta-analysis. Statistical Software R (version 4.4.0) was used to calculate odds ratio (OR) and standardized mean differences using a random-effect model with a 95% confidence interval (CI) and <i>p</i>-value less than 0.05.ResultsEight studies, encompassing 1076 patients, were included in the analysis. These comprised three randomized controlled trials and five nonrandomized studies. The majority of these studies exhibited some concerns regarding bias. Hemoadsorption group showed lower discharge mortality (OR: 0.58, 95% CI: 0.33-1.00, <i>p</i> = 0.05) compared to controls, but no significant disparity is observed in other outcomes. In-hospital outcomes also showed higher heterogeneity, with an <i>I</i>² value greater than 50%.ConclusionCytoSorb use in patients undergoing cardiac surgery with CPB used for IE has no impact on operative mortality and morbidity but has a beneficial effect on discharge mortality.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"2184923251328119"},"PeriodicalIF":0.7,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143732118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Milky heart: A rare case of tuberculous chylopericardium managed conservatively.
IF 0.7 Q3 Medicine Pub Date : 2025-03-24 DOI: 10.1177/02184923251324961
Kevin Paul DA Enriquez, John Christopher A Pilapil, Bynlee Stuart Go, Rafael Luis C Gavino, Michelle Marie Pipo, Felix Eduardo R Punzalan

IntroductionTuberculosis (TB) is a rare cause of chylopericardium. Optimal management remains unclear.Methods/ResultsA 30-year-old Filipino male presented with recurrent massive pericardial effusions, with pericardiostomy revealing chylopericardium. Microbiologic TB studies were negative, and other etiologies were excluded. Pericardial fluid adenosine deaminase was elevated; anti-TB regimen was initiated, leading to resolution.DiscussionThere is no consensus about the optimal management of TB chylopericardium. Adenosine deaminase represents a useful test to diagnose TB in inflammatory, lymphocyte-predominant effusions, especially when other tests are negative. Failed conservative management merits more invasive approaches.ConclusionWhile data remain lacking, this case suggests that TB chylopericardium responds to anti-TB therapy.

{"title":"Milky heart: A rare case of tuberculous chylopericardium managed conservatively.","authors":"Kevin Paul DA Enriquez, John Christopher A Pilapil, Bynlee Stuart Go, Rafael Luis C Gavino, Michelle Marie Pipo, Felix Eduardo R Punzalan","doi":"10.1177/02184923251324961","DOIUrl":"https://doi.org/10.1177/02184923251324961","url":null,"abstract":"<p><p>IntroductionTuberculosis (TB) is a rare cause of chylopericardium. Optimal management remains unclear.Methods/ResultsA 30-year-old Filipino male presented with recurrent massive pericardial effusions, with pericardiostomy revealing chylopericardium. Microbiologic TB studies were negative, and other etiologies were excluded. Pericardial fluid adenosine deaminase was elevated; anti-TB regimen was initiated, leading to resolution.DiscussionThere is no consensus about the optimal management of TB chylopericardium. Adenosine deaminase represents a useful test to diagnose TB in inflammatory, lymphocyte-predominant effusions, especially when other tests are negative. Failed conservative management merits more invasive approaches.ConclusionWhile data remain lacking, this case suggests that TB chylopericardium responds to anti-TB therapy.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"2184923251324961"},"PeriodicalIF":0.7,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143693666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral tumoral pulmonary emboli complicating right atrial myxoma.
IF 0.7 Q3 Medicine Pub Date : 2025-03-17 DOI: 10.1177/02184923251328067
Albaraa Bara, Nawal Akashe, Ahmad Walid Izzat, Eyad M Chatty, Mohammad Bashar Izzat

A 48-year-old female underwent emergency surgery for an undetermined mass in the right atrium associated with bilateral pulmonary artery emboli. Under deep hypothermic circulatory arrest, a large gelatinous mass was excised from the right atrium, and large embolic lumps were removed from both main pulmonary arteries. Histopathological testing of excised specimens confirmed the diagnosis of a vascularized myxoma. At 6 months of follow-up, repeated transthoracic echocardiography has not shown any signs of local recurrence or elevated pulmonary artery pressure. The potential for right atrial myxoma as a source of pulmonary embolization should be borne in mind, as this potentially fatal yet curable condition demands emergency surgical intervention.

{"title":"Bilateral tumoral pulmonary emboli complicating right atrial myxoma.","authors":"Albaraa Bara, Nawal Akashe, Ahmad Walid Izzat, Eyad M Chatty, Mohammad Bashar Izzat","doi":"10.1177/02184923251328067","DOIUrl":"https://doi.org/10.1177/02184923251328067","url":null,"abstract":"<p><p>A 48-year-old female underwent emergency surgery for an undetermined mass in the right atrium associated with bilateral pulmonary artery emboli. Under deep hypothermic circulatory arrest, a large gelatinous mass was excised from the right atrium, and large embolic lumps were removed from both main pulmonary arteries. Histopathological testing of excised specimens confirmed the diagnosis of a vascularized myxoma. At 6 months of follow-up, repeated transthoracic echocardiography has not shown any signs of local recurrence or elevated pulmonary artery pressure. The potential for right atrial myxoma as a source of pulmonary embolization should be borne in mind, as this potentially fatal yet curable condition demands emergency surgical intervention.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"2184923251328067"},"PeriodicalIF":0.7,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143651190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hybrid support systems: A shift in managing infarct-related cardiogenic shock.
IF 0.7 Q3 Medicine Pub Date : 2025-03-17 DOI: 10.1177/02184923251328392
Hamrish Kumar Rajakumar
{"title":"Hybrid support systems: A shift in managing infarct-related cardiogenic shock.","authors":"Hamrish Kumar Rajakumar","doi":"10.1177/02184923251328392","DOIUrl":"https://doi.org/10.1177/02184923251328392","url":null,"abstract":"","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"2184923251328392"},"PeriodicalIF":0.7,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143651194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variations in thromboelastography levels in blood exposed to membrane oxygenators.
IF 0.7 Q3 Medicine Pub Date : 2025-03-17 DOI: 10.1177/02184923251327042
Masashi Tagaya, Shinya Okano, Takuo Murataka, Hiroki Handa, Shunsuke Ichikawa, Shunsuke Takahashi

IntroductionThromboelastography (TEG), which indicates hemostatic ability, is useful for monitoring coagulation during extracorporeal circulation (ECC). However, the extent to which TEG levels are independently affected by ECC exposure remains unclear. To determine the effects of TEG levels in blood exposed to a membrane oxygenator, we performed in vitro experiments using whole human blood with ECC circuits including a membrane oxygenator.MethodsBlood provided by healthy volunteers was heparinized and circulated in three types of experimental circuits: polymer-coating, heparin-coating (HC), or non-coating (NC) membrane oxygenators (five of each type). Thromboelastography tests using a global hemostasis assay were performed at 3, 6, 12, and 24 h of circulation in each experiment. During TEG, the sampled blood was reversed with 0.05 mg of protamine. One-way analysis of variance (ANOVA) and two-way repeated measures ANOVA were performed to evaluate trends in circulation duration and coating types, respectively.ResultsCitrated kaolin with heparinase reaction times (CKHR) were significantly shortened at 6 and 12 h but prolonged at 24 h. The maximum amplitude for citrated kaolin with heparinase (CKHMA) was magnified from 6 to 12 h. Regarding the coating type, a significant difference was observed between HC and NC in CKHR at 6 h, but significance was not noted in other comparisons of coating types in CKHR and CKHMA.ConclusionsThromboelastography data indicated that the hemostatic capability of blood exposed to membrane surfaces was maintained after 12 h of circulation. The effects on TEG data in terms of coating type remain to be determined.

{"title":"Variations in thromboelastography levels in blood exposed to membrane oxygenators.","authors":"Masashi Tagaya, Shinya Okano, Takuo Murataka, Hiroki Handa, Shunsuke Ichikawa, Shunsuke Takahashi","doi":"10.1177/02184923251327042","DOIUrl":"https://doi.org/10.1177/02184923251327042","url":null,"abstract":"<p><p>IntroductionThromboelastography (TEG), which indicates hemostatic ability, is useful for monitoring coagulation during extracorporeal circulation (ECC). However, the extent to which TEG levels are independently affected by ECC exposure remains unclear. To determine the effects of TEG levels in blood exposed to a membrane oxygenator, we performed in vitro experiments using whole human blood with ECC circuits including a membrane oxygenator.MethodsBlood provided by healthy volunteers was heparinized and circulated in three types of experimental circuits: polymer-coating, heparin-coating (HC), or non-coating (NC) membrane oxygenators (five of each type). Thromboelastography tests using a global hemostasis assay were performed at 3, 6, 12, and 24 h of circulation in each experiment. During TEG, the sampled blood was reversed with 0.05 mg of protamine. One-way analysis of variance (ANOVA) and two-way repeated measures ANOVA were performed to evaluate trends in circulation duration and coating types, respectively.ResultsCitrated kaolin with heparinase reaction times (CKHR) were significantly shortened at 6 and 12 h but prolonged at 24 h. The maximum amplitude for citrated kaolin with heparinase (CKHMA) was magnified from 6 to 12 h. Regarding the coating type, a significant difference was observed between HC and NC in CKHR at 6 h, but significance was not noted in other comparisons of coating types in CKHR and CKHMA.ConclusionsThromboelastography data indicated that the hemostatic capability of blood exposed to membrane surfaces was maintained after 12 h of circulation. The effects on TEG data in terms of coating type remain to be determined.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"2184923251327042"},"PeriodicalIF":0.7,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143651203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Superior vena cava syndrome caused by a giant right coronary artery aneurysm.
IF 0.7 Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-02-04 DOI: 10.1177/02184923251317752
Hagen Kahlbau, João João Mendes, Isabel Fragata, José Fragata

We present the case of a 61-year-old male who was admitted with superior vena cava syndrome. Patient's medical history includes a coronary artery bypass surgery 5 years ago. Echocardiography and computed tomography angiography showed a giant right coronary artery aneurysm compressing the superior vena cava. Due to hemodynamic deterioration, emergent cardiac surgery was performed to alleviate the compression, and veno-arterial extracorporal membrane oxygenation (VA ECMO) was necessary during intensive care unit. Hemodynamic improvement over 6 days allowed for successful ECMO weaning and eventually patient's discharge.

{"title":"Superior vena cava syndrome caused by a giant right coronary artery aneurysm.","authors":"Hagen Kahlbau, João João Mendes, Isabel Fragata, José Fragata","doi":"10.1177/02184923251317752","DOIUrl":"10.1177/02184923251317752","url":null,"abstract":"<p><p>We present the case of a 61-year-old male who was admitted with superior vena cava syndrome. Patient's medical history includes a coronary artery bypass surgery 5 years ago. Echocardiography and computed tomography angiography showed a giant right coronary artery aneurysm compressing the superior vena cava. Due to hemodynamic deterioration, emergent cardiac surgery was performed to alleviate the compression, and veno-arterial extracorporal membrane oxygenation (VA ECMO) was necessary during intensive care unit. Hemodynamic improvement over 6 days allowed for successful ECMO weaning and eventually patient's discharge.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"49-51"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Failing DeVega tricuspid valve repair due to detachment of annuloplasty sutures: The Bowstring (Guitar string) sign.
IF 0.7 Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-02-03 DOI: 10.1177/02184923251318060
Mohammad Amin Shojaei, Soheila Salari, Saeid Hosseini

The DeVega annuloplasty procedure involves a double-running suture line along the circumference of the tricuspid annulus, encircling the anterior and posterior leaflets. A rare mechanical complication of this technique is the detachment of the suturing from the annulus, which can be referred to as the "bowstring sign" or "guitar string sign."

{"title":"Failing DeVega tricuspid valve repair due to detachment of annuloplasty sutures: The Bowstring (Guitar string) sign.","authors":"Mohammad Amin Shojaei, Soheila Salari, Saeid Hosseini","doi":"10.1177/02184923251318060","DOIUrl":"10.1177/02184923251318060","url":null,"abstract":"<p><p>The DeVega annuloplasty procedure involves a double-running suture line along the circumference of the tricuspid annulus, encircling the anterior and posterior leaflets. A rare mechanical complication of this technique is the detachment of the suturing from the annulus, which can be referred to as the \"bowstring sign\" or \"guitar string sign.\"</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"87-88"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143123023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Traumatic chylothorax management post-coronary artery bypass grafting - A systematic review.
IF 0.7 Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-02-23 DOI: 10.1177/02184923251321541
Gavin John Carmichael, Duron Prinsloo, Connor Bentley, Rodan Prinsloo, Joshua G Kovoor, Mathew O Jacob, Aashray Gupta

IntroductionCoronary artery bypass graft (CABG) surgery is performed globally around 400,000 times annually. Despite its benefits, CABG can lead to complications, including chylothorax, a rare condition where chyle accumulates in the pleural cavity due to thoracic duct trauma. Currently, there are no international guidelines for traumatic chylothorax management post-CABG. This is the first systematic review to provide a comprehensive overview of the current state of management for chylothorax post-CABG.MethodsThis systematic review was conducted by searching EMBASE, Cochrane, Ovid and PubMed databases on 16 June 2024. The inclusion criteria focused on studies addressing post-CABG chylothorax management and reporting clinical outcomes. Data was extracted from 11 studies focusing on graft type, complications and management strategies.ResultsThis review included 11 case report studies with 14 cases of post-CABG chylothorax. Conservative management was attempted in all cases, with varying components such as total parenteral nutrition, nil by mouth, octreotide and low-fat diets. High-output chylothorax (>1000 mL/day) often necessitated surgical intervention after an average of 12.5 days of conservative management. Surgical approaches included thoracic duct ligation, embolisation and pleurodesis. Surgical ligation was effective in three cases, while thoracic duct embolisation was successful in one case.ConclusionsChylothorax post-CABG is managed initially with conservative strategies, but high-output cases often necessitate surgical intervention. This review highlights the need for standardised guidelines, regarding the timing of surgical escalation and the use of octreotide and somatostatin. Further research should focus on higher-powered studies to validate these findings and establish clinical guidelines for managing chylothorax post-CABG.

{"title":"Traumatic chylothorax management post-coronary artery bypass grafting - A systematic review.","authors":"Gavin John Carmichael, Duron Prinsloo, Connor Bentley, Rodan Prinsloo, Joshua G Kovoor, Mathew O Jacob, Aashray Gupta","doi":"10.1177/02184923251321541","DOIUrl":"10.1177/02184923251321541","url":null,"abstract":"<p><p>IntroductionCoronary artery bypass graft (CABG) surgery is performed globally around 400,000 times annually. Despite its benefits, CABG can lead to complications, including chylothorax, a rare condition where chyle accumulates in the pleural cavity due to thoracic duct trauma. Currently, there are no international guidelines for traumatic chylothorax management post-CABG. This is the first systematic review to provide a comprehensive overview of the current state of management for chylothorax post-CABG.MethodsThis systematic review was conducted by searching EMBASE, Cochrane, Ovid and PubMed databases on 16 June 2024. The inclusion criteria focused on studies addressing post-CABG chylothorax management and reporting clinical outcomes. Data was extracted from 11 studies focusing on graft type, complications and management strategies.ResultsThis review included 11 case report studies with 14 cases of post-CABG chylothorax. Conservative management was attempted in all cases, with varying components such as total parenteral nutrition, nil by mouth, octreotide and low-fat diets. High-output chylothorax (>1000 mL/day) often necessitated surgical intervention after an average of 12.5 days of conservative management. Surgical approaches included thoracic duct ligation, embolisation and pleurodesis. Surgical ligation was effective in three cases, while thoracic duct embolisation was successful in one case.ConclusionsChylothorax post-CABG is managed initially with conservative strategies, but high-output cases often necessitate surgical intervention. This review highlights the need for standardised guidelines, regarding the timing of surgical escalation and the use of octreotide and somatostatin. Further research should focus on higher-powered studies to validate these findings and establish clinical guidelines for managing chylothorax post-CABG.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"73-86"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11951393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multi-societal endorsement of the 2024 European guideline recommendations on coronary revascularization.
IF 0.7 Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-02-05 DOI: 10.1177/02184923251315320
Victor Dayan, Joseph F Sabik, Minoru Ono, Marc Ruel, Song Wan, Lars G Svensson, Leonard N Girardi, Y Joseph Woo, Vinay Badhwar, Marc R Moon, Wilson Szeto, Vinod H Thourani, Rui Almeida, Zhe Zheng, Walter J Gomes, Dawn S Hui, Rosemary F Kelly, Miguel Sousa Uva, Joanna Chikwe, Faisal G Bakaeen
{"title":"Multi-societal endorsement of the 2024 European guideline recommendations on coronary revascularization.","authors":"Victor Dayan, Joseph F Sabik, Minoru Ono, Marc Ruel, Song Wan, Lars G Svensson, Leonard N Girardi, Y Joseph Woo, Vinay Badhwar, Marc R Moon, Wilson Szeto, Vinod H Thourani, Rui Almeida, Zhe Zheng, Walter J Gomes, Dawn S Hui, Rosemary F Kelly, Miguel Sousa Uva, Joanna Chikwe, Faisal G Bakaeen","doi":"10.1177/02184923251315320","DOIUrl":"10.1177/02184923251315320","url":null,"abstract":"","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"28-31"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare presentation of a mediastinal retiniform type hemangioendothelioma.
IF 0.7 Q3 Medicine Pub Date : 2025-01-01 Epub Date: 2025-02-09 DOI: 10.1177/02184923251318388
Ubaldo E Rivas, Juan C Rendón, Eric E Vinck, Luis A Correa, Gustavo A Castilla, Bruno Ramírez Castillero

Cardiac tumors, whether primary (mostly benign) or secondary (metastatic), are extremely rare, and very few cases of retiniform hemangioendothelioma have been documented since its initial diagnosis in 1994. We present a 67-year-old male who presented with pericarditis, recurrent pericardial and pleural effusions. On computed axial tomography, an oval lesion located on the superior aspect of the left pulmonary pericardial recess within the transverse sinus, adjacent to the trunk of the pulmonary artery. In the operating room, after dissection and resection of the mass, the histopathological diagnosis of retiniform hemangioendothelioma was confirmed.

{"title":"A rare presentation of a mediastinal retiniform type hemangioendothelioma.","authors":"Ubaldo E Rivas, Juan C Rendón, Eric E Vinck, Luis A Correa, Gustavo A Castilla, Bruno Ramírez Castillero","doi":"10.1177/02184923251318388","DOIUrl":"10.1177/02184923251318388","url":null,"abstract":"<p><p>Cardiac tumors, whether primary (mostly benign) or secondary (metastatic), are extremely rare, and very few cases of retiniform hemangioendothelioma have been documented since its initial diagnosis in 1994. We present a 67-year-old male who presented with pericarditis, recurrent pericardial and pleural effusions. On computed axial tomography, an oval lesion located on the superior aspect of the left pulmonary pericardial recess within the transverse sinus, adjacent to the trunk of the pulmonary artery. In the operating room, after dissection and resection of the mass, the histopathological diagnosis of retiniform hemangioendothelioma was confirmed.</p>","PeriodicalId":35950,"journal":{"name":"ASIAN CARDIOVASCULAR & THORACIC ANNALS","volume":" ","pages":"41-44"},"PeriodicalIF":0.7,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
ASIAN CARDIOVASCULAR & THORACIC ANNALS
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1